StreetInsider.com Pre-Open Movers:

Vanda Pharmaceuticals (Nasdaq: VNDA) 60% HIGHER; positive Phase 3 trial data for schizophrenia drug Iloperidone ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE